Daniel A. Nadeau

403 total citations
13 papers, 318 citations indexed

About

Daniel A. Nadeau is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Physiology. According to data from OpenAlex, Daniel A. Nadeau has authored 13 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Pharmacology and 3 papers in Physiology. Recurrent topics in Daniel A. Nadeau's work include Diabetes Treatment and Management (7 papers), Diabetes Management and Research (6 papers) and Pharmacology and Obesity Treatment (4 papers). Daniel A. Nadeau is often cited by papers focused on Diabetes Treatment and Management (7 papers), Diabetes Management and Research (6 papers) and Pharmacology and Obesity Treatment (4 papers). Daniel A. Nadeau collaborates with scholars based in United States, United Kingdom and Australia. Daniel A. Nadeau's co-authors include K. Sreekumaran Nair, Jaime A. Davidson, Janet B. McGill, Philip Raskin, Rickey R. Reinhardt, David Bell, Robert R. Henry, Richard L. Weinstein, Bruce W. Bode and G. C. Ford and has published in prestigious journals such as Diabetes Care, Analytical Biochemistry and Obesity.

In The Last Decade

Daniel A. Nadeau

13 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel A. Nadeau United States 9 175 95 79 61 44 13 318
Melissa A. Morgan United States 9 136 0.8× 69 0.7× 99 1.3× 23 0.4× 40 0.9× 11 348
K. A. Lockman United Kingdom 8 125 0.7× 99 1.0× 49 0.6× 86 1.4× 31 0.7× 21 332
Justin Mathew United States 8 190 1.1× 57 0.6× 105 1.3× 93 1.5× 113 2.6× 17 484
Arkadiusz Michalak Poland 10 136 0.8× 122 1.3× 72 0.9× 118 1.9× 39 0.9× 36 329
Jine Wu China 8 93 0.5× 35 0.4× 73 0.9× 29 0.5× 46 1.0× 18 329
Brenda Dorcely United States 8 176 1.0× 42 0.4× 110 1.4× 54 0.9× 54 1.2× 14 344
Jerome S. Fischer United States 8 447 2.6× 212 2.2× 93 1.2× 172 2.8× 21 0.5× 11 507
Rebecca Cleeton United States 8 248 1.4× 53 0.6× 64 0.8× 35 0.6× 135 3.1× 14 416
Maki Okudaira Japan 6 246 1.4× 84 0.9× 44 0.6× 128 2.1× 39 0.9× 9 392
Sibylle Dellweg Germany 11 430 2.5× 268 2.8× 77 1.0× 180 3.0× 58 1.3× 15 604

Countries citing papers authored by Daniel A. Nadeau

Since Specialization
Citations

This map shows the geographic impact of Daniel A. Nadeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Nadeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Nadeau more than expected).

Fields of papers citing papers by Daniel A. Nadeau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel A. Nadeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Nadeau. The network helps show where Daniel A. Nadeau may publish in the future.

Co-authorship network of co-authors of Daniel A. Nadeau

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel A. Nadeau. A scholar is included among the top collaborators of Daniel A. Nadeau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel A. Nadeau. Daniel A. Nadeau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Pham, David Q., et al.. (2015). Inhaled Technosphere Insulin: A Novel Delivery System and Formulation for the Treatment of Types 1 and 2 Diabetes Mellitus. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 35(3). 298–314. 15 indexed citations
2.
3.
4.
Oyer, David S., et al.. (2011). Ease of use and preference of a new versus widely available prefilled insulin pen assessed by people with diabetes, physicians and nurses. Expert Opinion on Drug Delivery. 8(10). 1259–1269. 25 indexed citations
5.
6.
Nadeau, Daniel A.. (2010). Partnering with Patients to Improve Therapeutic Outcomes: Incretin-Based Therapy for Type 2 Diabetes. Postgraduate Medicine. 122(3). 7–15. 5 indexed citations
7.
Henderson, Gregory C., Daniel A. Nadeau, Edward S. Horton, & K. Sreekumaran Nair. (2010). Effects of Adiposity and 30 Days of Caloric Restriction Upon Protein Metabolism in Moderately vs. Severely Obese Women. Obesity. 18(6). 1135–1142. 13 indexed citations
8.
Nadeau, Daniel A., et al.. (2009). Treatment Considerations for Diabetes: A Pharmacist’s Guide to Improving Care in the Elderly. Journal of Pharmacy Practice. 22(6). 575–587. 1 indexed citations
9.
Joseph, James A. & Daniel A. Nadeau. (2008). Diet Sehat dengan Kode Warna Makanan. Andalas University Repository (Andalas University). 2 indexed citations
10.
Bode, Bruce W., Richard L. Weinstein, David Bell, et al.. (2002). Comparison of Insulin Aspart With Buffered Regular Insulin and Insulin Lispro in Continuous Subcutaneous Insulin Infusion. Diabetes Care. 25(3). 439–444. 105 indexed citations
11.
Nadeau, Daniel A.. (2000). Intestinal Warfare: The Role of Short‐Chain Fructooligosaccharides in Health and Disease. 3(5). 266–273. 11 indexed citations
12.
Balagopal, Prabhakaran, G. C. Ford, David B. Ebenstein, Daniel A. Nadeau, & K. Sreekumaran Nair. (1996). Mass Spectrometric Methods for Determination of [13C]Leucine Enrichment in Human Muscle Protein. Analytical Biochemistry. 239(1). 77–85. 48 indexed citations
13.
Rosenfeld, Stuart A., et al.. (1996). Production and Purification of Recombinant Hirudin Expressed in the Methylotrophic YeastPichia pastoris. Protein Expression and Purification. 8(4). 476–482. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melissa A. Morgan Breakdown of academic impact, for papers by K. A. Lockman Breakdown of academic impact, for papers by Justin Mathew Breakdown of academic impact, for papers by Arkadiusz Michalak Breakdown of academic impact, for papers by Jine Wu Breakdown of academic impact, for papers by Brenda Dorcely Breakdown of academic impact, for papers by Jerome S. Fischer Breakdown of academic impact, for papers by Rebecca Cleeton Breakdown of academic impact, for papers by Maki Okudaira Breakdown of academic impact, for papers by Sibylle Dellweg
Rankless by CCL
2026